Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$908M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$441M |
| 3 |
KLA
KLAC
|
+$424M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$328M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$1.71B |
| 2 |
Bank of America
BAC
|
+$1.61B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 4 |
CB
CHUBB CORPORATION
CB
|
+$716M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$493M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.24% |
| 2 | Energy | 3.39% |
| 3 | Technology | 3.32% |
| 4 | Healthcare | 2.54% |
| 5 | Consumer Discretionary | 2.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5526
CALL
Brookdale Senior Living
BKD
$3.43B
| $105K | ﹤0.01% |
6,600
-64,600
| -91% | -$986K |
|
|
EXAS
5527
CALL
DELISTED
Exact Sciences
EXAS
| $105K | ﹤0.01% |
15,600
-1,400
| -8% | -$8.96K |
|
5528
Lindblad Expeditions
LIND
$2.23B
| $105K | ﹤0.01% |
10,540
-22,605
| -68% | -$228K |
|
5529
Invesco CEF Income Composite ETF
PCEF
$811M
| $105K | ﹤0.01% |
4,848
-34,642
| -88% | -$715K |
|
|
IOC
5530
PUT
DELISTED
Interoil Corporation
IOC
| $105K | ﹤0.01% |
3,300
-17,700
| -84% | -$498K |
|
5531
Banco de Chile
BCH
$21.3B
| $104K | ﹤0.01% |
5,202
-116
| -2% | -$2.21K |
|
5532
Cardiff Oncology
CRDF
$74.7M
| $104K | ﹤0.01% |
312
+260
| +500% | +$88.5K |
|
|
SGYP
5533
PUT
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $104K | ﹤0.01% |
37,600
+34,900
| +1,293% | +$126K |
|
|
PWE
5534
PUT
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $104K | ﹤0.01% |
112,100
-280,000
| -71% | -$239K |
|
|
NQS
5535
DELISTED
NUVEEN SELECT QUALITY MUNI FD
NQS
| $104K | ﹤0.01% |
7,090
+52
| +0.7% | +$745 |
|
5536
Ring Energy
REI
$325M
| $103K | ﹤0.01% |
20,471
+19,682
| +2,495% | +$97.7K |
|
|
AXAS
5537
DELISTED
Abraxas Petroleum Corp
AXAS
| $103K | ﹤0.01% |
5,071
+1,981
| +64% | +$38.6K |
|
|
IMDZ
5538
DELISTED
Immune Design Corp.
IMDZ
| $103K | ﹤0.01% |
7,944
+3,383
| +74% | +$39.1K |
|
5539
PUT
Interactive Brokers
IBKR
$38.8B
| $102K | ﹤0.01% |
+10,400
| New | +$91.8K |
|
|
MMD
5540
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$280M
| $102K | ﹤0.01% |
5,180
+3,771
| +268% | +$72.5K |
|
5541
Ocular Therapeutix
OCUL
$1.92B
| $102K | ﹤0.01% |
10,522
+5,833
| +124% | +$44.2K |
|
|
PIM
5542
Franklin Master Intermediate Income Trust
PIM
$151M
| $102K | ﹤0.01% |
23,285
+17,047
| +273% | +$73.1K |
|
|
CUTR
5543
DELISTED
Cutera, Inc.
CUTR
| $102K | ﹤0.01% |
9,047
+9,046
| +904,600% | +$103K |
|
|
RXDX
5544
DELISTED
Ignyta, Inc.
RXDX
| $102K | ﹤0.01% |
15,005
+10,416
| +227% | +$85.8K |
|
|
CTIC
5545
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $102K | ﹤0.01% |
19,182
+12,618
| +192% | +$101K |
|
5546
iShares MSCI Italy ETF
EWI
$1.07B
| $101K | ﹤0.01% |
4,158
-3,630
| -47% | -$87.3K |
|
5547
Kopin
KOPN
$756M
| $101K | ﹤0.01% |
60,792
+34,531
| +131% | +$66K |
|
5548
NovoCure
NVCR
$1.83B
| $101K | ﹤0.01% |
6,984
+4,434
| +174% | +$63.6K |
|
|
SCD
5549
LMP Capital and Income Fund
SCD
$360M
| $101K | ﹤0.01% |
8,136
+119
| +1% | +$1.36K |
|
5550
Omega Flex
OFLX
$312M
| $100K | ﹤0.01% |
2,878
+1,959
| +213% | +$62.8K |
|
Similar funds
Citigroup's Q1 2016 Portfolio in Review
As of Q1 2016, Citigroup held 8,306 positions worth $89B, down 11% from $100B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $10.6B in Q1 2016, closing 570 positions and reducing 2,897 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $716M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.2% of assets, down from 9.1% a quarter earlier, followed by Energy and Technology.
Against the trend, Citigroup opened a new position in Global X Scientific Beta US ETF worth $11.1M.
- Citigroup's largest Q1 2016 buy was Global X Scientific Beta US ETF: 450,000 shares worth $11.1M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2016, an estimated $908M increase.
- Citigroup's biggest Q1 2016 reduction was Goldman Sachs, cutting an estimated $1.71B.
- Citigroup fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $716M.
- Citigroup's ten largest holdings make up 28% of its $89B portfolio in Q1 2016.
- Citigroup opened 495 new positions and closed 570 in Q1 2016.
- Citigroup's portfolio value fell 11% quarter-over-quarter to $89B.
Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.